8p23.1 microdeletion syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:251071Q93.5
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

8p23.1 microdeletion syndrome (also known as chromosome 8p23.1 deletion syndrome or monosomy 8p23.1) is a rare chromosomal disorder caused by a submicroscopic deletion on the short arm of chromosome 8 at band p23.1. This region contains several important genes, including GATA4, which plays a critical role in heart development. As a result, congenital heart defects — particularly atrioventricular septal defects (AVSD), atrial septal defects, and other structural cardiac anomalies — are among the most prominent features of this syndrome. The deletion can occur de novo or may be inherited from a carrier parent who harbors a balanced rearrangement (such as an inversion) involving the 8p23.1 region. Affected individuals typically present with intellectual disability ranging from mild to moderate, developmental delay, speech and language difficulties, and behavioral problems including features overlapping with attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder. Characteristic facial features may include a high and broad forehead, arched eyebrows, a short nose with a broad nasal bridge, low-set ears, and a thin upper lip. Additional findings can include microcephaly, diaphragmatic hernia (particularly congenital diaphragmatic hernia, or CDH), and growth restriction. There is no cure for 8p23.1 microdeletion syndrome, and management is supportive and symptom-based. Congenital heart defects often require surgical correction. Early intervention programs including speech therapy, occupational therapy, and special educational support are recommended to optimize developmental outcomes. Behavioral and psychological support may also be beneficial. Regular follow-up with a multidisciplinary team including cardiologists, developmental pediatricians, and geneticists is important for comprehensive care.

Also known as:

Clinical phenotype terms— hover any for plain English:

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for 8p23.1 microdeletion syndrome.

View clinical trials →

No actively recruiting trials found for 8p23.1 microdeletion syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the 8p23.1 microdeletion syndrome community →

No specialists are currently listed for 8p23.1 microdeletion syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to 8p23.1 microdeletion syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open 8p23.1 microdeletion syndromeForum →

No community posts yet. Be the first to share your experience with 8p23.1 microdeletion syndrome.

Start the conversation →

Latest news about 8p23.1 microdeletion syndrome

No recent news articles for 8p23.1 microdeletion syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about 8p23.1 microdeletion syndrome

What is 8p23.1 microdeletion syndrome?

8p23.1 microdeletion syndrome (also known as chromosome 8p23.1 deletion syndrome or monosomy 8p23.1) is a rare chromosomal disorder caused by a submicroscopic deletion on the short arm of chromosome 8 at band p23.1. This region contains several important genes, including GATA4, which plays a critical role in heart development. As a result, congenital heart defects — particularly atrioventricular septal defects (AVSD), atrial septal defects, and other structural cardiac anomalies — are among the most prominent features of this syndrome. The deletion can occur de novo or may be inherited from a

At what age does 8p23.1 microdeletion syndrome typically begin?

Typical onset of 8p23.1 microdeletion syndrome is neonatal. Age of onset can vary across affected individuals.